Obesity-associated gastrointestinal tract cancer: From beginning to end

Cancer

Volumn 120, Issue 7, 2014, Pages 935-939

  Berger, Nathan A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR;

ALCOHOL CONSUMPTION; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; HUMAN; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SIGNAL TRANSDUCTION; TOBACCO CONSUMPTION; TONGUE TUMOR;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; OBESITY; TONGUE NEOPLASMS;

EID: 84899438034     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28534     Document Type: Review

References (58)

1. Demark-Wahnefried W, Platz EA, Ligibel JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012; 8: 1244-1259.
2. Hursting SD, Digiovanni J, Dannenberg AJ, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila). 2012; 5: 1260-1272.
3. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr,. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999; 341: 1097-1105.
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MC,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638.
5. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer. 2004; 4: 579-591.
6. Ballard-Barbash R, Berrigan D, Potischman N, Dowling E,. Obesity and cancer epidemiology. In:, Berger NA, ed. Cancer and Energy Balance, Epidemiology and Overview. New York: Springer; 2010: 1-45.
7. Nock NL, Berger NA,. Obesity and cancer: overview of mechanisms. In:, Berger NA, ed. Cancer and Energy Balance, Epidemiology and Overview. New York: Springer; 2010: 129-179.
8. Nock NL,. Obesity and gastrointestinal cancers: epidemiology. In:, Markowitz SD, Berger NA, eds. Energy Balance and Gastrointestinal Cancer. New York: Springer; 2012: 1-22.
9. Teras LR, Patel AV,. The epidemiology of obesity and hematologic malignancies. In:, Mittelman SD, Berger NA, eds. Energy Balance and Hematologic Malignancies. New York: Springer; 2012: 1-30.
10. Loi S, Milne R, Freidlander ML,. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1686-1691.
11. Wasan HS, Novelli M, Bee J, Bodmer WF,. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci USA. 1997; 94: 3308-3313.
12. Hata K, Kubota M, Shimizu M, et al. C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms. Int J Mol Sci. 2011; 12: 8133-8145.
13. Day SD, Enos RT, McClellan JL, Steiner JL, Velazquez KT, Murphy EA,. Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer. Cytokine. 2013; 64: 454-462.
14. Iyengar N, Kochhar A, Morris P, et al. Impact of obesity on survival of patients in early stage squamous cell carcinoma of the oral tongue. Cancer. 2014; 120: 983-991.
15. Purdue MP, Hashibe M, Berthiller J, et al. Type of alcoholic beverage and risk of head and neck cancer-a pooled analysis within the INHANCE Consortium. Am J Epidemiol. 2009; 169: 132-142.
16. Gaudet MM, Olshan AF, Chuang SC, et al. Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol. 2010; 39: 1091-1102.
17. Lubin JH, Muscat J, Gaudet MM, et al. An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control. 2011; 22: 1217-1231.
18. Deneuve S, Tan HK, Eghiaian A, Temam S,. Management and outcome of head and neck squamous cell carcinomas in obese patients. Oral Oncol. 2011; 47: 631-635.
19. Vaughan TL, Davis S, Kristal A, Thomas DB,. Obesity, alcohol, and tobacco as risk factors for cancers of esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995; 4: 85-92.
20. Griggs JJ, Mangu PB, Anderson H, et al. American Society of Clinical Oncology. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2012; 30: 1553-1561.
21. Lyman GH, Sparreboom A,. Chemotherapy dosing in overweight and obese patients with cancer. Nat Rev Clin Oncol. 2013; 10: 451-459.
22. Key TJ, Allen NE, Verkasalo PK, Banks E,. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc. 2001; 60: 81-89.
23. Tchernof A, Despres JP,. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res. 2000; 32: 526-536.
24. Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP,. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 2009; 15: 6529-6540.
25. Yuan TL, Cantley LC,. P13K pathway alternation in cancer: variations on a theme. Oncogene. 2008; 27: 5497-5510.
26. Amornphimolthan P, Patel V, Sodhi A, et al. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res. 2005; 65: 9953-9961.
27. Amornphimiltham P, Sriuranpong V, Patel V, et al. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target of UCN-01. Clin Cancer Res. 2004; 10 (12 pt 1): 4029-4037.
28. Molinolo AA, Hewitt SM, Amornphimoltham P, et al. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res. 2007; 13: 4964-4973.
29. Schneider A, Younis RH, Gutkind JS,. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia. 2008; 10: 1295-1302.
30. Vitale-Cross L, Molinolo AA, Martin D, et al. Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prev Res (Phila). 2012; 5: 565-573.
31. Zheng Q, Dunlap SM, Zhu J, et al. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer. 2011; 18: 491-503.
32. Zheng Q, Banaszak L, Fracci S, et al. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer. 2013; 20: 797-808.
33. Liu K, Jiang M, Lu Y, et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell. 2013; 12: 304-315.
34. Rao SK, Pavicevic Z, Du Z, et al. Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem. 2010; 285: 325-321.
35. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose expression of tumor necrosis factor in human obesity and insulin resistance. J Clin Invest. 1995; 95: 2409-2415.
36. Lumeng C,. Adipose tissue macrophages in obesity, inflammation and cancer. In:, Dannenberg AJ, Berger NA, eds. Obesity, Inflammation and Cancer (Energy Balance and Cancer). New York: Springer; 2013: 83-98.
37. Ouchi N, Parker JL, Lugus JJ, Walsh K,. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11: 85-97.
38. Iyengar NM, Morris PG, Hudis CA, Dannenberg AJ,. Obesity, inflammation, and breast cancer. In:, Dannenberg AJ, Berger NA, eds. Obesity, Inflammation and Cancer (Energy Balance and Cancer). New York: Springer; 2013: 181-217.
39. Rao SK, Pavicevic Z, Du Z, et al. Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem. 2010; 284: 32512-32521.
40. Jeng JH, Wang YJ, Chiang BL, et al. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis. 2003; 24: 1301-1315.
41. Feller L, Altini M, Lemmer J,. Inflammation in the context of oral cancer. Oral Oncol. 2013; 49: 887-892.
42. Costa NL, Valadres MC, Souza PP, et al. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma. Oral Oncol. 2013; 48: 216-223.
43. Plottel CS, Blaser MJ,. Microbiome and malignancy. Cell Host Microbe. 2011; 10: 324-335.
44. Peek RM Jr, Blaser MJ,. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002; 2: 28-37.
45. McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO,. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013; 8: e53653.
46. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013; 14: 207-215.
47. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW,. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β- catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14: 195-206.
48. Konstantinov SR, Kuipers EJ, Peppelenbosch MP,. Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol. 2013; 10: 741-745.
49. Bachhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI,. Host-bacterial mutualism in the human intestine. Science. 2005; 307: 1915-1920.
50. Tig H, Kaser A,. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011; 121: 2126-2132.
51. zur Hausen H,. Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 2009; 384: 260-265.
52. Center for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012; 61: 258-261.
53. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
54. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001; 344: 1125-1131.
55. Heck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010; 39: 166-181.
56. Maruthur NM, Bolen SD, Brancati FL, Clark JM,. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring). 2009; 17: 375-381.
57. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105: 175-201.
58. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012; 62: 30-67.